Results 11 to 20 of about 10,950,669 (421)

Evaluation of resources for analyzing drug interactions

open access: yesJournal of the Medical Library Association, 2017
Objective: The research sought to evaluate seven drug information resources, specifically designed for analyzing drug interactions for scope, completeness, and ease of use, and determine the consistency of content among the seven resources.
Risha I. Patel, Robert D. Beckett
doaj   +2 more sources

Drug-drug interactions with raltegravir

open access: yesEuropean Journal of Medical Research, 2009
To review all currently published drug-drug interaction studies with the HIV-integrase inhibitor raltegravir.A PubMed search was conducted for all published reports up to August 1, 2009 as well as a review of updated European and US Prescriber's Information (EMEA and FDA) and abstracts from recent international scientific meetings.A total of 14 drug ...
Burger David M
openaire   +6 more sources

Insights into CYP2B6-mediated drug–drug interactions

open access: yesActa Pharmaceutica Sinica B, 2016
Mounting evidence demonstrates that CYP2B6 plays a much larger role in human drug metabolism than was previously believed. The discovery of multiple important substrates of CYP2B6 as well as polymorphic differences has sparked increasing interest in the ...
William D. Hedrich   +2 more
doaj   +2 more sources

Renal drug transporters and their significance in drug–drug interactions

open access: yesActa Pharmaceutica Sinica B, 2016
The kidney is a vital organ for the elimination of therapeutic drugs and their metabolites. Renal drug transporters, which are primarily located in the renal proximal tubules, play an important role in tubular secretion and reabsorption of drug molecules
Jia Yin, Joanne Wang
doaj   +2 more sources

A Review of Approaches for Predicting Drug–Drug Interactions Based on Machine Learning

open access: yesFrontiers in Pharmacology, 2022
Drug–drug interactions play a vital role in drug research. However, they may also cause adverse reactions in patients, with serious consequences. Manual detection of drug–drug interactions is time-consuming and expensive, so it is urgent to use computer ...
Ke Han   +9 more
semanticscholar   +1 more source

Crystal structure correlations with the intrinsic thermodynamics of human carbonic anhydrase inhibitor binding [PDF]

open access: yesPeerJ, 2018
The structure-thermodynamics correlation analysis was performed for a series of fluorine- and chlorine-substituted benzenesulfonamide inhibitors binding to several human carbonic anhydrase (CA) isoforms.
Alexey Smirnov   +4 more
doaj   +2 more sources

Prevalence and Clinical Significance of Drug–Drug and Drug–Dietary Supplement Interactions among Patients Admitted for Cardiothoracic Surgery in Greece

open access: yesPharmaceutics, 2021
Background: Drug interactions represent a major issue in clinical settings, especially for critically ill patients such as those with cardiovascular disease (CVD) who require cardiothoracic surgery (CTS) and receive a high number of different medications.
Marios Spanakis   +4 more
doaj   +1 more source

DPDDI: a deep predictor for drug-drug interactions

open access: yesBMC Bioinformatics, 2020
The treatment of complex diseases by taking multiple drugs becomes increasingly popular. However, drug-drug interactions (DDIs) may give rise to the risk of unanticipated adverse effects and even unknown toxicity.
Yue-Hua Feng, Shaowu Zhang, Jian-Yu Shi
semanticscholar   +1 more source

CASTER: Predicting Drug Interactions with Chemical Substructure Representation [PDF]

open access: yesAAAI Conference on Artificial Intelligence, 2019
Adverse drug-drug interactions (DDIs) remain a leading cause of morbidity and mortality. Identifying potential DDIs during the drug design process is critical for patients and society.
Kexin Huang   +4 more
semanticscholar   +1 more source

Pharmacovigilance of Drug-Drug Interactions with Nirmatrelvir/Ritonavir. [PDF]

open access: yesInfect Dis Ther
Introduction Nirmatrelvir/ritonavir (NMV/r) is approved in the United States (US) and more than 70 other countries for the treatment of mild to moderate COVID-19 in nonhospitalized adults at high risk for severe disease.
Hendrick V   +8 more
europepmc   +2 more sources

Home - About - Disclaimer - Privacy